[1P-0582] Whole-exome analysis of mouse lung tumors induced by fetal radiation and postnatal chemical carcinogen exposures

^○Yoshiko Amasaki¹, Atsuko Ishikawa¹, Kazuhiro Daino¹, Takamitsu Morioka¹, Yoshiya Shimada², Shizuko Kakinuma¹ (1.Dept. of Radiation. Effects Res., NIRS, QST, 2.Ins. for Envi. Sci.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0583] Possibility of tricelluler tight junction LSR/Angulin-1 antibody in therapy for human endometrioid endometrial carcinoma

^○Kimihito Saito¹, Takayuki Kohno², Takumi Konno², Tadahi Okada¹, Hiroshi Shimada¹, Seiro Satohisa³, Masuo Kondoh⁴, Tsuyoshi Saito¹, Takashi Kojima² (1.Dept.of Obst. ＆ Gynecol., Sapporo Med. Univ. Sch. of Med., 2.Dept. of Cell Sci., Res. Inst. for Frontier Med., Sapporo Med. Univ. Sch. of Med., 3.Hoyukai Sapporo Obst.& Gynecol. Clinic, 4.Grad.Sch. of Pharm. Sci., Osaka Univ)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0584] HMGA1 is upregulated in myelodysplastic syndromes and blocks myeloid differentiation.

^○Kazutoshi Ebisawa¹, Yosuke Masamoto¹, Mineo Kurokawa^{1, 2} (1.Tokyo Univ.. Hematol&Oncol, 2.Tokyo Univ. Hospital, Cell therapy)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0585] Tyrosine kinase inhibitor, nintedanib ameliorates rheumatoid arthritis associated interstitial lung disease by reducing peptidyl deiminase 4+ alveolar epithelial cells with epithelial-mesenchymal transition

^○Satoshi Kanazawa, Yoko Miura (Dept. of Neu. Disorder Genet., Nagoya City Univ. Grad. Sch.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0586] The novel antitumor effect of anti-SIRPα/β1 antibodies via macrophages

^○Yoji Murata¹, Mariko Sakamoto^{1, 2}, Takeshi Okamoto¹, Yasuyuki Saito¹, Takenori Kotani¹, Masato Fujisawa², Takashi Matozaki¹ (1.Div. Mol. & Cell. Signal., Kobe Univ. Grad. Sch. Med., 2.Div. Uro. Med., Kobe Univ. Grad. Sch. Med)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0587] Gastrointestinal microbiota and clinical characteristics in patients with advanced solid tumors (SCRUM-Japan MONSTAR-SCREEN project)

^○Kentaro Sawada¹, Riu Yamashita², Satoshi Horasawa³, Ayumu Yoshikawa⁴, Takao Fujisawa⁵, Shigenori Kadowaki⁶, Makoto Ueno⁷, Eiji Oki⁸, Ken Kato⁹, Daisuke Aoki¹⁰, Taro Sato¹¹, Yoshito Komatsu¹², Taito Esaki¹³, Hiroya Taniguchi⁶, Yoshiaki Nakamura^{3, 4}, Hideaki Bando^{3, 4}, Takayuki Yoshino⁴ (1.Department of Oncology, Kushiro Rosai Hospital, 2.Translational Informatics, National Cancer Center Hospital East, 3.Translational Research Support Section, National Cancer Center Hospital East, 4.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 5.Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6.Department of Clinical Oncology, Aichi Cancer Center Hospital, 7.Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 8.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 9.Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital, 10.Department of Obstetrics and Gynecology, Keio University School of Medicine, 11.Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, 12.Department of Cancer Center, Hokkaido University Hospital, 13.Gastrointestinal and Medical Oncology Division, National Hospital Organization Kyushu Cancer Center)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0588] Characteristics of cancer cells and response on HDAC inhibitors in p63-positive salivary gland duct carcinoma

^○MASAYA NAKANO¹, KIZUKU OOWADA¹, TAKUMI KONNO², KAZUHUMI OBATA², TAKUYA KAKUKI¹, RYO MIYATA¹, MAKOTO KUROSE¹, ATUSHI KONDO¹, KENICHI TAKANO¹, TAKAYUKI KOHNO², TAKASHI KOJIMA² (1.Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, 060-8556 Japan, 2.Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0589] ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells

^○Junichi Yamamoto¹, Yuki Yamaguchi¹, Hiroshi Handa² (1.Sch. of Life Sci. and Tech., Tokyo Tech., 2.Dept. of Chemical Biology, Tokyo Med.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0590] Development and evaluation of α-ray nuclide labeled antibodies

^○Mayu Higashi¹, Kazuya Kabayama¹, Yuichiro Kadonaga¹, Koutaro Goto², Wataru Tsukimura², Akio Matsuda², Masamori Mizuno², Koichi Fukase¹ (1.Dept. of Chem., Grad. Sch. of Sci., Osaka Univ., 2.The Noguchi Institute)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[1P-0591] Structure-Activity Relationship Study of Rumbrin against T-ALL-derived CCRF-CEM Cells

^○Yuki Fujita¹, Chihiro Yoshida¹, Tomoya Higashi¹, Chihiro Nakata^{2, 3}, Shota Hoyano^{2, 4}, Fumiya Seki^{2, 5}, Nobuo Kitada^{1, 6}, Takashi Hirano¹, Shojiro Maki^{1, 6} (1.Dept. of Info. Sci., Grad. Sch., Univ. of Electro-Communications, 2.Stem Cell Project.,Tokyo Metropolitan Institute of Medical Science, 3.Dept. of Med. and Dent., Univ. of Tokyo Medical and Dental, 4.Dept. of Stem Cell reg., Univ. of Tokyo Metropolitan, 5.Dept. of Sci. and Eng.,Univ. of Chuo, 6.Center for Neuro Sci. and BioMed. Eng., Univ. of Electro-Communications)

The 44th Annual Meeting of the Molecular Biology Society of Japan